Cargando…
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360951/ https://www.ncbi.nlm.nih.gov/pubmed/34385448 http://dx.doi.org/10.1038/s41467-021-25285-0 |
_version_ | 1783737853179592704 |
---|---|
author | Ribas, Antoni Algazi, Alain Ascierto, Paolo A. Butler, Marcus O. Chandra, Sunandana Gordon, Michael Hernandez-Aya, Leonel Lawrence, Donald Lutzky, Jose Miller, Wilson H. Campbell, Katie M. Delafont, Bruno Marshall, Shannon Mueller, Nancy Robert, Caroline |
author_facet | Ribas, Antoni Algazi, Alain Ascierto, Paolo A. Butler, Marcus O. Chandra, Sunandana Gordon, Michael Hernandez-Aya, Leonel Lawrence, Donald Lutzky, Jose Miller, Wilson H. Campbell, Katie M. Delafont, Bruno Marshall, Shannon Mueller, Nancy Robert, Caroline |
author_sort | Ribas, Antoni |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8360951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83609512021-08-19 Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma Ribas, Antoni Algazi, Alain Ascierto, Paolo A. Butler, Marcus O. Chandra, Sunandana Gordon, Michael Hernandez-Aya, Leonel Lawrence, Donald Lutzky, Jose Miller, Wilson H. Campbell, Katie M. Delafont, Bruno Marshall, Shannon Mueller, Nancy Robert, Caroline Nat Commun Author Correction Nature Publishing Group UK 2021-08-12 /pmc/articles/PMC8360951/ /pubmed/34385448 http://dx.doi.org/10.1038/s41467-021-25285-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Ribas, Antoni Algazi, Alain Ascierto, Paolo A. Butler, Marcus O. Chandra, Sunandana Gordon, Michael Hernandez-Aya, Leonel Lawrence, Donald Lutzky, Jose Miller, Wilson H. Campbell, Katie M. Delafont, Bruno Marshall, Shannon Mueller, Nancy Robert, Caroline Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
title | Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
title_full | Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
title_fullStr | Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
title_full_unstemmed | Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
title_short | Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
title_sort | author correction: pd-l1 blockade in combination with inhibition of mapk oncogenic signaling in patients with advanced melanoma |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360951/ https://www.ncbi.nlm.nih.gov/pubmed/34385448 http://dx.doi.org/10.1038/s41467-021-25285-0 |
work_keys_str_mv | AT ribasantoni authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT algazialain authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT asciertopaoloa authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT butlermarcuso authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT chandrasunandana authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT gordonmichael authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT hernandezayaleonel authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT lawrencedonald authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT lutzkyjose authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT millerwilsonh authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT campbellkatiem authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT delafontbruno authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT marshallshannon authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT muellernancy authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma AT robertcaroline authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma |